nodes	percent_of_prediction	percent_of_DWPC	metapath
Cysteamine—MPO—Carboplatin—breast cancer	0.239	1	CbGbCtD
Cysteamine—SST—embryo—breast cancer	0.00952	0.143	CbGeAlD
Cysteamine—SST—epithelium—breast cancer	0.00777	0.117	CbGeAlD
Cysteamine—SST—endometrium—breast cancer	0.00697	0.105	CbGeAlD
Cysteamine—SST—pituitary gland—breast cancer	0.00631	0.0946	CbGeAlD
Cysteamine—SST—female reproductive system—breast cancer	0.00577	0.0866	CbGeAlD
Cysteamine—SST—adrenal gland—breast cancer	0.00563	0.0845	CbGeAlD
Cysteamine—SST—endocrine gland—breast cancer	0.00488	0.0733	CbGeAlD
Cysteamine—SST—lymph node—breast cancer	0.00338	0.0507	CbGeAlD
Cysteamine—MPO—epithelium—breast cancer	0.00313	0.0469	CbGeAlD
Cysteamine—MPO—skin of body—breast cancer	0.00298	0.0447	CbGeAlD
Cysteamine—MPO—pituitary gland—breast cancer	0.00254	0.0381	CbGeAlD
Cysteamine—MPO—adrenal gland—breast cancer	0.00227	0.034	CbGeAlD
Cysteamine—MPO—bone marrow—breast cancer	0.00219	0.0329	CbGeAlD
Cysteamine—MPO—endocrine gland—breast cancer	0.00197	0.0295	CbGeAlD
Cysteamine—MPO—lymph node—breast cancer	0.00136	0.0204	CbGeAlD
Cysteamine—Abdominal pain—Irinotecan—breast cancer	0.000206	0.000538	CcSEcCtD
Cysteamine—Abdominal pain—Mitoxantrone—breast cancer	0.000206	0.000538	CcSEcCtD
Cysteamine—Body temperature increased—Mitoxantrone—breast cancer	0.000206	0.000538	CcSEcCtD
Cysteamine—Body temperature increased—Irinotecan—breast cancer	0.000206	0.000538	CcSEcCtD
Cysteamine—Feeling abnormal—Fluorouracil—breast cancer	0.000205	0.000537	CcSEcCtD
Cysteamine—Anaemia—Docetaxel—breast cancer	0.000204	0.000533	CcSEcCtD
Cysteamine—Anorexia—Paclitaxel—breast cancer	0.000202	0.000529	CcSEcCtD
Cysteamine—Vomiting—Vinorelbine—breast cancer	0.000201	0.000524	CcSEcCtD
Cysteamine—Body temperature increased—Gemcitabine—breast cancer	0.0002	0.000524	CcSEcCtD
Cysteamine—Tremor—Capecitabine—breast cancer	0.0002	0.000523	CcSEcCtD
Cysteamine—Renal failure—Methotrexate—breast cancer	0.0002	0.000522	CcSEcCtD
Cysteamine—Dizziness—Thiotepa—breast cancer	0.000199	0.000521	CcSEcCtD
Cysteamine—Rash—Vinorelbine—breast cancer	0.000199	0.00052	CcSEcCtD
Cysteamine—Dermatitis—Vinorelbine—breast cancer	0.000199	0.00052	CcSEcCtD
Cysteamine—Urticaria—Fluorouracil—breast cancer	0.000198	0.000518	CcSEcCtD
Cysteamine—Headache—Vinorelbine—breast cancer	0.000198	0.000517	CcSEcCtD
Cysteamine—Leukopenia—Docetaxel—breast cancer	0.000197	0.000516	CcSEcCtD
Cysteamine—Anaemia—Capecitabine—breast cancer	0.000197	0.000516	CcSEcCtD
Cysteamine—Body temperature increased—Fluorouracil—breast cancer	0.000197	0.000515	CcSEcCtD
Cysteamine—Hypersensitivity—Mitoxantrone—breast cancer	0.000192	0.000501	CcSEcCtD
Cysteamine—Hypersensitivity—Irinotecan—breast cancer	0.000192	0.000501	CcSEcCtD
Cysteamine—Vomiting—Thiotepa—breast cancer	0.000192	0.000501	CcSEcCtD
Cysteamine—Leukopenia—Capecitabine—breast cancer	0.000191	0.000499	CcSEcCtD
Cysteamine—Convulsion—Docetaxel—breast cancer	0.000191	0.000499	CcSEcCtD
Cysteamine—Hypertension—Docetaxel—breast cancer	0.00019	0.000497	CcSEcCtD
Cysteamine—Rash—Thiotepa—breast cancer	0.00019	0.000497	CcSEcCtD
Cysteamine—Dermatitis—Thiotepa—breast cancer	0.00019	0.000496	CcSEcCtD
Cysteamine—Headache—Thiotepa—breast cancer	0.000189	0.000493	CcSEcCtD
Cysteamine—Somnolence—Paclitaxel—breast cancer	0.000189	0.000493	CcSEcCtD
Cysteamine—Nausea—Vinorelbine—breast cancer	0.000187	0.00049	CcSEcCtD
Cysteamine—Renal failure—Epirubicin—breast cancer	0.000187	0.000489	CcSEcCtD
Cysteamine—Dyspepsia—Paclitaxel—breast cancer	0.000187	0.000488	CcSEcCtD
Cysteamine—Asthenia—Irinotecan—breast cancer	0.000187	0.000488	CcSEcCtD
Cysteamine—Asthenia—Mitoxantrone—breast cancer	0.000187	0.000488	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	0.000186	0.000487	CcSEcCtD
Cysteamine—Decreased appetite—Paclitaxel—breast cancer	0.000184	0.000482	CcSEcCtD
Cysteamine—Hypertension—Capecitabine—breast cancer	0.000184	0.000482	CcSEcCtD
Cysteamine—Hypersensitivity—Fluorouracil—breast cancer	0.000184	0.00048	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Paclitaxel—breast cancer	0.000183	0.000479	CcSEcCtD
Cysteamine—Fatigue—Paclitaxel—breast cancer	0.000183	0.000478	CcSEcCtD
Cysteamine—Asthenia—Gemcitabine—breast cancer	0.000182	0.000475	CcSEcCtD
Cysteamine—Constipation—Paclitaxel—breast cancer	0.000181	0.000474	CcSEcCtD
Cysteamine—Confusional state—Docetaxel—breast cancer	0.000181	0.000474	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	0.00018	0.000472	CcSEcCtD
Cysteamine—Urinary tract disorder—Methotrexate—breast cancer	0.00018	0.000471	CcSEcCtD
Cysteamine—Anaphylactic shock—Docetaxel—breast cancer	0.00018	0.00047	CcSEcCtD
Cysteamine—Discomfort—Capecitabine—breast cancer	0.000179	0.000469	CcSEcCtD
Cysteamine—Nausea—Thiotepa—breast cancer	0.000179	0.000468	CcSEcCtD
Cysteamine—Urethral disorder—Methotrexate—breast cancer	0.000179	0.000468	CcSEcCtD
Cysteamine—Diarrhoea—Irinotecan—breast cancer	0.000178	0.000465	CcSEcCtD
Cysteamine—Diarrhoea—Mitoxantrone—breast cancer	0.000178	0.000465	CcSEcCtD
Cysteamine—Nervous system disorder—Docetaxel—breast cancer	0.000176	0.000461	CcSEcCtD
Cysteamine—Confusional state—Capecitabine—breast cancer	0.000176	0.000459	CcSEcCtD
Cysteamine—Feeling abnormal—Paclitaxel—breast cancer	0.000175	0.000457	CcSEcCtD
Cysteamine—Skin disorder—Docetaxel—breast cancer	0.000175	0.000457	CcSEcCtD
Cysteamine—Gastrointestinal pain—Paclitaxel—breast cancer	0.000173	0.000454	CcSEcCtD
Cysteamine—Diarrhoea—Gemcitabine—breast cancer	0.000173	0.000453	CcSEcCtD
Cysteamine—Renal failure—Doxorubicin—breast cancer	0.000173	0.000452	CcSEcCtD
Cysteamine—Dizziness—Irinotecan—breast cancer	0.000172	0.00045	CcSEcCtD
Cysteamine—Anorexia—Docetaxel—breast cancer	0.000171	0.000448	CcSEcCtD
Cysteamine—Nervous system disorder—Capecitabine—breast cancer	0.000171	0.000446	CcSEcCtD
Cysteamine—Diarrhoea—Fluorouracil—breast cancer	0.00017	0.000446	CcSEcCtD
Cysteamine—Skin disorder—Capecitabine—breast cancer	0.000169	0.000442	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—VEGFC—breast cancer	0.000169	0.000542	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—CSF2—breast cancer	0.000169	0.000541	CbGpPWpGaD
Cysteamine—Urinary tract disorder—Epirubicin—breast cancer	0.000169	0.000441	CcSEcCtD
Cysteamine—Urticaria—Paclitaxel—breast cancer	0.000169	0.000441	CcSEcCtD
Cysteamine—Connective tissue disorder—Epirubicin—breast cancer	0.000168	0.000439	CcSEcCtD
Cysteamine—Abdominal pain—Paclitaxel—breast cancer	0.000168	0.000439	CcSEcCtD
Cysteamine—Body temperature increased—Paclitaxel—breast cancer	0.000168	0.000439	CcSEcCtD
Cysteamine—Urethral disorder—Epirubicin—breast cancer	0.000167	0.000438	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—JAG2—breast cancer	0.000166	0.000534	CbGpPWpGaD
Cysteamine—Anorexia—Capecitabine—breast cancer	0.000166	0.000434	CcSEcCtD
Cysteamine—Vomiting—Mitoxantrone—breast cancer	0.000165	0.000433	CcSEcCtD
Cysteamine—Vomiting—Irinotecan—breast cancer	0.000165	0.000433	CcSEcCtD
Cysteamine—Immune system disorder—Methotrexate—breast cancer	0.000165	0.000431	CcSEcCtD
Cysteamine—Dizziness—Fluorouracil—breast cancer	0.000165	0.000431	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—WNT1—breast cancer	0.000164	0.000526	CbGpPWpGaD
Cysteamine—Rash—Mitoxantrone—breast cancer	0.000164	0.000429	CcSEcCtD
Cysteamine—Rash—Irinotecan—breast cancer	0.000164	0.000429	CcSEcCtD
Cysteamine—Dermatitis—Irinotecan—breast cancer	0.000164	0.000429	CcSEcCtD
Cysteamine—Dermatitis—Mitoxantrone—breast cancer	0.000164	0.000429	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—PLA2G4A—breast cancer	0.000164	0.000525	CbGpPWpGaD
Cysteamine—Headache—Mitoxantrone—breast cancer	0.000163	0.000426	CcSEcCtD
Cysteamine—Headache—Irinotecan—breast cancer	0.000163	0.000426	CcSEcCtD
Cysteamine—SST—Signaling Pathways—NOTCH4—breast cancer	0.000162	0.00052	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—CSF2—breast cancer	0.000162	0.000519	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—GZMB—breast cancer	0.000161	0.000517	CbGpPWpGaD
Cysteamine—Vomiting—Gemcitabine—breast cancer	0.000161	0.000421	CcSEcCtD
Cysteamine—Somnolence—Docetaxel—breast cancer	0.00016	0.000418	CcSEcCtD
Cysteamine—MPO—C-MYB transcription factor network—HRAS—breast cancer	0.00016	0.000512	CbGpPWpGaD
Cysteamine—Mental disorder—Methotrexate—breast cancer	0.00016	0.000418	CcSEcCtD
Cysteamine—Rash—Gemcitabine—breast cancer	0.00016	0.000418	CcSEcCtD
Cysteamine—Dermatitis—Gemcitabine—breast cancer	0.00016	0.000417	CcSEcCtD
Cysteamine—Erythema—Methotrexate—breast cancer	0.000159	0.000415	CcSEcCtD
Cysteamine—Malnutrition—Methotrexate—breast cancer	0.000159	0.000415	CcSEcCtD
Cysteamine—Headache—Gemcitabine—breast cancer	0.000159	0.000415	CcSEcCtD
Cysteamine—Vomiting—Fluorouracil—breast cancer	0.000158	0.000414	CcSEcCtD
Cysteamine—Dyspepsia—Docetaxel—breast cancer	0.000158	0.000414	CcSEcCtD
Cysteamine—Rash—Fluorouracil—breast cancer	0.000157	0.000411	CcSEcCtD
Cysteamine—Dermatitis—Fluorouracil—breast cancer	0.000157	0.00041	CcSEcCtD
Cysteamine—SST—Signaling Pathways—AGTR2—breast cancer	0.000156	0.000502	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CXCL2—breast cancer	0.000156	0.000502	CbGpPWpGaD
Cysteamine—Decreased appetite—Docetaxel—breast cancer	0.000156	0.000409	CcSEcCtD
Cysteamine—Hypersensitivity—Paclitaxel—breast cancer	0.000156	0.000409	CcSEcCtD
Cysteamine—Headache—Fluorouracil—breast cancer	0.000156	0.000408	CcSEcCtD
Cysteamine—Urinary tract disorder—Doxorubicin—breast cancer	0.000156	0.000408	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—NOTCH4—breast cancer	0.000156	0.000499	CbGpPWpGaD
Cysteamine—Gastrointestinal disorder—Docetaxel—breast cancer	0.000155	0.000406	CcSEcCtD
Cysteamine—Connective tissue disorder—Doxorubicin—breast cancer	0.000155	0.000406	CcSEcCtD
Cysteamine—Fatigue—Docetaxel—breast cancer	0.000155	0.000405	CcSEcCtD
Cysteamine—Urethral disorder—Doxorubicin—breast cancer	0.000155	0.000405	CcSEcCtD
Cysteamine—SST—Signaling Pathways—PTHLH—breast cancer	0.000155	0.000496	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—BMP2—breast cancer	0.000155	0.000496	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—GZMB—breast cancer	0.000155	0.000495	CbGpPWpGaD
Cysteamine—Nausea—Irinotecan—breast cancer	0.000155	0.000404	CcSEcCtD
Cysteamine—Nausea—Mitoxantrone—breast cancer	0.000155	0.000404	CcSEcCtD
Cysteamine—Immune system disorder—Epirubicin—breast cancer	0.000154	0.000403	CcSEcCtD
Cysteamine—Constipation—Docetaxel—breast cancer	0.000154	0.000402	CcSEcCtD
Cysteamine—Dyspepsia—Capecitabine—breast cancer	0.000153	0.000401	CcSEcCtD
Cysteamine—Asthenia—Paclitaxel—breast cancer	0.000152	0.000398	CcSEcCtD
Cysteamine—Decreased appetite—Capecitabine—breast cancer	0.000151	0.000396	CcSEcCtD
Cysteamine—Nausea—Gemcitabine—breast cancer	0.000151	0.000394	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Capecitabine—breast cancer	0.00015	0.000393	CcSEcCtD
Cysteamine—Fatigue—Capecitabine—breast cancer	0.00015	0.000393	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—AGTR2—breast cancer	0.00015	0.000481	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CXCL2—breast cancer	0.00015	0.000481	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—EDNRB—breast cancer	0.00015	0.00048	CbGpPWpGaD
Cysteamine—Mental disorder—Epirubicin—breast cancer	0.00015	0.000391	CcSEcCtD
Cysteamine—Constipation—Capecitabine—breast cancer	0.000149	0.000389	CcSEcCtD
Cysteamine—Erythema—Epirubicin—breast cancer	0.000149	0.000389	CcSEcCtD
Cysteamine—Malnutrition—Epirubicin—breast cancer	0.000149	0.000389	CcSEcCtD
Cysteamine—SST—Signaling Pathways—PGR—breast cancer	0.000148	0.000476	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PTHLH—breast cancer	0.000148	0.000476	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—BMP2—breast cancer	0.000148	0.000476	CbGpPWpGaD
Cysteamine—Feeling abnormal—Docetaxel—breast cancer	0.000148	0.000388	CcSEcCtD
Cysteamine—Nausea—Fluorouracil—breast cancer	0.000148	0.000387	CcSEcCtD
Cysteamine—SST—Signaling Pathways—THBS1—breast cancer	0.000148	0.000473	CbGpPWpGaD
Cysteamine—MPO—Selenium Micronutrient Network—IL6—breast cancer	0.000147	0.000473	CbGpPWpGaD
Cysteamine—Gastrointestinal pain—Docetaxel—breast cancer	0.000147	0.000385	CcSEcCtD
Cysteamine—Anaemia—Methotrexate—breast cancer	0.000147	0.000384	CcSEcCtD
Cysteamine—Tension—Epirubicin—breast cancer	0.000146	0.000381	CcSEcCtD
Cysteamine—Diarrhoea—Paclitaxel—breast cancer	0.000145	0.00038	CcSEcCtD
Cysteamine—Nervousness—Epirubicin—breast cancer	0.000144	0.000377	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—EDNRB—breast cancer	0.000144	0.000461	CbGpPWpGaD
Cysteamine—Feeling abnormal—Capecitabine—breast cancer	0.000143	0.000375	CcSEcCtD
Cysteamine—Immune system disorder—Doxorubicin—breast cancer	0.000143	0.000373	CcSEcCtD
Cysteamine—Gastrointestinal pain—Capecitabine—breast cancer	0.000142	0.000372	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—PGR—breast cancer	0.000142	0.000456	CbGpPWpGaD
Cysteamine—Body temperature increased—Docetaxel—breast cancer	0.000142	0.000372	CcSEcCtD
Cysteamine—Abdominal pain—Docetaxel—breast cancer	0.000142	0.000372	CcSEcCtD
Cysteamine—Leukopenia—Methotrexate—breast cancer	0.000142	0.000372	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—THBS1—breast cancer	0.000142	0.000454	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—FLT1—breast cancer	0.000141	0.000452	CbGpPWpGaD
Cysteamine—Dizziness—Paclitaxel—breast cancer	0.00014	0.000367	CcSEcCtD
Cysteamine—SST—Signaling Pathways—FGF3—breast cancer	0.00014	0.00045	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—SQSTM1—breast cancer	0.00014	0.00045	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—PIK3CG—breast cancer	0.00014	0.000447	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—JAG1—breast cancer	0.000138	0.000444	CbGpPWpGaD
Cysteamine—Mental disorder—Doxorubicin—breast cancer	0.000138	0.000362	CcSEcCtD
Cysteamine—Urticaria—Capecitabine—breast cancer	0.000138	0.000362	CcSEcCtD
Cysteamine—SST—Signaling Pathways—NOTCH3—breast cancer	0.000138	0.000442	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PARP1—breast cancer	0.000138	0.000442	CbGpPWpGaD
Cysteamine—Body temperature increased—Capecitabine—breast cancer	0.000138	0.00036	CcSEcCtD
Cysteamine—Abdominal pain—Capecitabine—breast cancer	0.000138	0.00036	CcSEcCtD
Cysteamine—Convulsion—Methotrexate—breast cancer	0.000138	0.00036	CcSEcCtD
Cysteamine—Malnutrition—Doxorubicin—breast cancer	0.000138	0.00036	CcSEcCtD
Cysteamine—Erythema—Doxorubicin—breast cancer	0.000138	0.00036	CcSEcCtD
Cysteamine—Anaemia—Epirubicin—breast cancer	0.000137	0.000359	CcSEcCtD
Cysteamine—Agitation—Epirubicin—breast cancer	0.000137	0.000357	CcSEcCtD
Cysteamine—SST—Signaling Pathways—CALCA—breast cancer	0.000136	0.000437	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—FLT1—breast cancer	0.000135	0.000433	CbGpPWpGaD
Cysteamine—Tension—Doxorubicin—breast cancer	0.000135	0.000353	CcSEcCtD
Cysteamine—Vomiting—Paclitaxel—breast cancer	0.000135	0.000353	CcSEcCtD
Cysteamine—SST—Signaling Pathways—RPS6—breast cancer	0.000135	0.000432	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—SQSTM1—breast cancer	0.000134	0.000431	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—FGF3—breast cancer	0.000134	0.000431	CbGpPWpGaD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	0.000134	0.000351	CcSEcCtD
Cysteamine—NPY2R—GPCR downstream signaling—PIK3CG—breast cancer	0.000134	0.000429	CbGpPWpGaD
Cysteamine—Rash—Paclitaxel—breast cancer	0.000134	0.00035	CcSEcCtD
Cysteamine—Dermatitis—Paclitaxel—breast cancer	0.000134	0.000349	CcSEcCtD
Cysteamine—Discomfort—Methotrexate—breast cancer	0.000134	0.000349	CcSEcCtD
Cysteamine—SST—Signaling Pathways—FGF4—breast cancer	0.000134	0.000428	CbGpPWpGaD
Cysteamine—Nervousness—Doxorubicin—breast cancer	0.000134	0.000349	CcSEcCtD
Cysteamine—SST—Signaling Pathways—CXCR4—breast cancer	0.000133	0.000427	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CXCL12—breast cancer	0.000133	0.000427	CbGpPWpGaD
Cysteamine—Leukopenia—Epirubicin—breast cancer	0.000133	0.000348	CcSEcCtD
Cysteamine—Headache—Paclitaxel—breast cancer	0.000133	0.000348	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—JAG1—breast cancer	0.000133	0.000426	CbGpPWpGaD
Cysteamine—Hypersensitivity—Docetaxel—breast cancer	0.000132	0.000346	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—PARP1—breast cancer	0.000132	0.000424	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—NOTCH3—breast cancer	0.000132	0.000424	CbGpPWpGaD
Cysteamine—Confusional state—Methotrexate—breast cancer	0.000131	0.000342	CcSEcCtD
Cysteamine—SST—Signaling Pathways—PAK1—breast cancer	0.000131	0.000419	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CALCA—breast cancer	0.000131	0.000419	CbGpPWpGaD
Cysteamine—Anaphylactic shock—Methotrexate—breast cancer	0.00013	0.000339	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—RPS6—breast cancer	0.000129	0.000414	CbGpPWpGaD
Cysteamine—Asthenia—Docetaxel—breast cancer	0.000129	0.000337	CcSEcCtD
Cysteamine—Convulsion—Epirubicin—breast cancer	0.000129	0.000337	CcSEcCtD
Cysteamine—Hypertension—Epirubicin—breast cancer	0.000128	0.000336	CcSEcCtD
Cysteamine—SST—Signaling Pathways—TCF7L2—breast cancer	0.000128	0.000411	CbGpPWpGaD
Cysteamine—Hypersensitivity—Capecitabine—breast cancer	0.000128	0.000335	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—FGF4—breast cancer	0.000128	0.000411	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—AKT2—breast cancer	0.000128	0.000409	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CXCR4—breast cancer	0.000128	0.000409	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CXCL12—breast cancer	0.000128	0.000409	CbGpPWpGaD
Cysteamine—Nervous system disorder—Methotrexate—breast cancer	0.000127	0.000332	CcSEcCtD
Cysteamine—Anaemia—Doxorubicin—breast cancer	0.000127	0.000332	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—PIK3CG—breast cancer	0.000127	0.000406	CbGpPWpGaD
Cysteamine—Agitation—Doxorubicin—breast cancer	0.000126	0.00033	CcSEcCtD
Cysteamine—Nausea—Paclitaxel—breast cancer	0.000126	0.00033	CcSEcCtD
Cysteamine—Skin disorder—Methotrexate—breast cancer	0.000126	0.000329	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	0.000126	0.000329	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—PAK1—breast cancer	0.000125	0.000401	CbGpPWpGaD
Cysteamine—Discomfort—Epirubicin—breast cancer	0.000125	0.000327	CcSEcCtD
Cysteamine—Asthenia—Capecitabine—breast cancer	0.000125	0.000327	CcSEcCtD
Cysteamine—SST—Signaling Pathways—HSP90AA1—breast cancer	0.000124	0.000397	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—NOTCH2—breast cancer	0.000124	0.000397	CbGpPWpGaD
Cysteamine—Anorexia—Methotrexate—breast cancer	0.000124	0.000323	CcSEcCtD
Cysteamine—Leukopenia—Doxorubicin—breast cancer	0.000123	0.000322	CcSEcCtD
Cysteamine—Diarrhoea—Docetaxel—breast cancer	0.000123	0.000322	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—TCF7L2—breast cancer	0.000123	0.000394	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—PIK3CD—breast cancer	0.000123	0.000393	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—AKT2—breast cancer	0.000122	0.000393	CbGpPWpGaD
Cysteamine—Confusional state—Epirubicin—breast cancer	0.000122	0.00032	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—PIK3CG—breast cancer	0.000122	0.00039	CbGpPWpGaD
Cysteamine—Anaphylactic shock—Epirubicin—breast cancer	0.000121	0.000317	CcSEcCtD
Cysteamine—SST—Signaling Pathways—AGTR1—breast cancer	0.00012	0.000386	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PRL—breast cancer	0.00012	0.000386	CbGpPWpGaD
Cysteamine—Convulsion—Doxorubicin—breast cancer	0.000119	0.000312	CcSEcCtD
Cysteamine—Diarrhoea—Capecitabine—breast cancer	0.000119	0.000312	CcSEcCtD
Cysteamine—Nervous system disorder—Epirubicin—breast cancer	0.000119	0.000311	CcSEcCtD
Cysteamine—Dizziness—Docetaxel—breast cancer	0.000119	0.000311	CcSEcCtD
Cysteamine—Hypertension—Doxorubicin—breast cancer	0.000119	0.00031	CcSEcCtD
Cysteamine—SST—Signaling Pathways—STK11—breast cancer	0.000119	0.00038	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—ADAM10—breast cancer	0.000119	0.00038	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—NOTCH2—breast cancer	0.000119	0.00038	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—HSP90AA1—breast cancer	0.000119	0.00038	CbGpPWpGaD
Cysteamine—Skin disorder—Epirubicin—breast cancer	0.000118	0.000308	CcSEcCtD
Cysteamine—NPY2R—GPCR downstream signaling—PIK3CD—breast cancer	0.000118	0.000377	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PLG—breast cancer	0.000117	0.000376	CbGpPWpGaD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	0.000116	0.000304	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—AKT2—breast cancer	0.000116	0.000372	CbGpPWpGaD
Cysteamine—Discomfort—Doxorubicin—breast cancer	0.000116	0.000302	CcSEcCtD
Cysteamine—Anorexia—Epirubicin—breast cancer	0.000116	0.000302	CcSEcCtD
Cysteamine—SST—Signaling Pathways—FGF10—breast cancer	0.000115	0.00037	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—AGTR1—breast cancer	0.000115	0.00037	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PRL—breast cancer	0.000115	0.00037	CbGpPWpGaD
Cysteamine—Somnolence—Methotrexate—breast cancer	0.000115	0.000301	CcSEcCtD
Cysteamine—Dizziness—Capecitabine—breast cancer	0.000115	0.000301	CcSEcCtD
Cysteamine—Vomiting—Docetaxel—breast cancer	0.000114	0.000299	CcSEcCtD
Cysteamine—Dyspepsia—Methotrexate—breast cancer	0.000114	0.000298	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—STK11—breast cancer	0.000114	0.000365	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—ADAM10—breast cancer	0.000114	0.000365	CbGpPWpGaD
Cysteamine—Rash—Docetaxel—breast cancer	0.000113	0.000296	CcSEcCtD
Cysteamine—Dermatitis—Docetaxel—breast cancer	0.000113	0.000296	CcSEcCtD
Cysteamine—Confusional state—Doxorubicin—breast cancer	0.000113	0.000296	CcSEcCtD
Cysteamine—Decreased appetite—Methotrexate—breast cancer	0.000113	0.000295	CcSEcCtD
Cysteamine—Headache—Docetaxel—breast cancer	0.000113	0.000295	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—PLG—breast cancer	0.000112	0.00036	CbGpPWpGaD
Cysteamine—Anaphylactic shock—Doxorubicin—breast cancer	0.000112	0.000293	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Methotrexate—breast cancer	0.000112	0.000293	CcSEcCtD
Cysteamine—Fatigue—Methotrexate—breast cancer	0.000112	0.000292	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—PIK3CD—breast cancer	0.000111	0.000357	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PDGFA—breast cancer	0.000111	0.000357	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—AKT2—breast cancer	0.000111	0.000356	CbGpPWpGaD
Cysteamine—Vomiting—Capecitabine—breast cancer	0.000111	0.000289	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—FGF10—breast cancer	0.000111	0.000355	CbGpPWpGaD
Cysteamine—Nervous system disorder—Doxorubicin—breast cancer	0.00011	0.000288	CcSEcCtD
Cysteamine—Rash—Capecitabine—breast cancer	0.00011	0.000287	CcSEcCtD
Cysteamine—SST—Signaling Pathways—TGFBR2—breast cancer	0.00011	0.000352	CbGpPWpGaD
Cysteamine—Dermatitis—Capecitabine—breast cancer	0.00011	0.000287	CcSEcCtD
Cysteamine—Headache—Capecitabine—breast cancer	0.000109	0.000285	CcSEcCtD
Cysteamine—Skin disorder—Doxorubicin—breast cancer	0.000109	0.000285	CcSEcCtD
Cysteamine—SST—Signaling Pathways—ITPR1—breast cancer	0.000108	0.000346	CbGpPWpGaD
Cysteamine—Somnolence—Epirubicin—breast cancer	0.000108	0.000282	CcSEcCtD
Cysteamine—SST—Signaling Pathways—ERBB4—breast cancer	0.000107	0.000344	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—STAT5A—breast cancer	0.000107	0.000344	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—MMP3—breast cancer	0.000107	0.000344	CbGpPWpGaD
Cysteamine—Anorexia—Doxorubicin—breast cancer	0.000107	0.00028	CcSEcCtD
Cysteamine—SST—GPCR downstream signaling—PIK3CB—breast cancer	0.000107	0.000343	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—PIK3CD—breast cancer	0.000107	0.000342	CbGpPWpGaD
Cysteamine—Nausea—Docetaxel—breast cancer	0.000107	0.000279	CcSEcCtD
Cysteamine—Feeling abnormal—Methotrexate—breast cancer	0.000107	0.000279	CcSEcCtD
Cysteamine—Dyspepsia—Epirubicin—breast cancer	0.000107	0.000279	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—PDGFA—breast cancer	0.000107	0.000342	CbGpPWpGaD
Cysteamine—Gastrointestinal pain—Methotrexate—breast cancer	0.000106	0.000277	CcSEcCtD
Cysteamine—Decreased appetite—Epirubicin—breast cancer	0.000105	0.000276	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—TGFBR2—breast cancer	0.000105	0.000337	CbGpPWpGaD
Cysteamine—Gastrointestinal disorder—Epirubicin—breast cancer	0.000105	0.000274	CcSEcCtD
Cysteamine—Fatigue—Epirubicin—breast cancer	0.000105	0.000273	CcSEcCtD
Cysteamine—SST—Signaling Pathways—SMAD4—breast cancer	0.000104	0.000333	CbGpPWpGaD
Cysteamine—Constipation—Epirubicin—breast cancer	0.000104	0.000271	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—ITPR1—breast cancer	0.000104	0.000332	CbGpPWpGaD
Cysteamine—Nausea—Capecitabine—breast cancer	0.000103	0.00027	CcSEcCtD
Cysteamine—SST—Signaling Pathways—IGF1R—breast cancer	0.000103	0.000331	CbGpPWpGaD
Cysteamine—Urticaria—Methotrexate—breast cancer	0.000103	0.000269	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—ERBB4—breast cancer	0.000103	0.00033	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—STAT5A—breast cancer	0.000103	0.00033	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—MMP3—breast cancer	0.000103	0.00033	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—CXCL8—breast cancer	0.000103	0.00033	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—PIK3CB—breast cancer	0.000103	0.000329	CbGpPWpGaD
Cysteamine—Abdominal pain—Methotrexate—breast cancer	0.000102	0.000268	CcSEcCtD
Cysteamine—Body temperature increased—Methotrexate—breast cancer	0.000102	0.000268	CcSEcCtD
Cysteamine—SST—Signaling Pathways—HES1—breast cancer	0.000101	0.000325	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PLA2G4A—breast cancer	0.000101	0.000323	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—NCOR1—breast cancer	0.000101	0.000323	CbGpPWpGaD
Cysteamine—Feeling abnormal—Epirubicin—breast cancer	9.99e-05	0.000261	CcSEcCtD
Cysteamine—Somnolence—Doxorubicin—breast cancer	9.98e-05	0.000261	CcSEcCtD
Cysteamine—SST—Signaling Pathways—FGF1—breast cancer	9.97e-05	0.00032	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CSF2—breast cancer	9.97e-05	0.00032	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—SMAD4—breast cancer	9.96e-05	0.000319	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—RAF1—breast cancer	9.95e-05	0.000319	CbGpPWpGaD
Cysteamine—Gastrointestinal pain—Epirubicin—breast cancer	9.92e-05	0.000259	CcSEcCtD
Cysteamine—SST—Signaling Pathways—NRG1—breast cancer	9.9e-05	0.000317	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—IGF1R—breast cancer	9.9e-05	0.000317	CbGpPWpGaD
Cysteamine—Dyspepsia—Doxorubicin—breast cancer	9.88e-05	0.000258	CcSEcCtD
Cysteamine—NPY2R—GPCR downstream signaling—CXCL8—breast cancer	9.85e-05	0.000316	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—H2AFX—breast cancer	9.83e-05	0.000315	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—IL2—breast cancer	9.82e-05	0.000315	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—E2F1—breast cancer	9.76e-05	0.000313	CbGpPWpGaD
Cysteamine—Decreased appetite—Doxorubicin—breast cancer	9.76e-05	0.000255	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—HES1—breast cancer	9.72e-05	0.000312	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—PIK3CB—breast cancer	9.71e-05	0.000311	CbGpPWpGaD
Cysteamine—Gastrointestinal disorder—Doxorubicin—breast cancer	9.69e-05	0.000253	CcSEcCtD
Cysteamine—Fatigue—Doxorubicin—breast cancer	9.68e-05	0.000253	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—NCOR1—breast cancer	9.67e-05	0.00031	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PLA2G4A—breast cancer	9.67e-05	0.00031	CbGpPWpGaD
Cysteamine—Urticaria—Epirubicin—breast cancer	9.64e-05	0.000252	CcSEcCtD
Cysteamine—Constipation—Doxorubicin—breast cancer	9.6e-05	0.000251	CcSEcCtD
Cysteamine—Body temperature increased—Epirubicin—breast cancer	9.59e-05	0.000251	CcSEcCtD
Cysteamine—Abdominal pain—Epirubicin—breast cancer	9.59e-05	0.000251	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—FGF1—breast cancer	9.56e-05	0.000306	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CSF2—breast cancer	9.56e-05	0.000306	CbGpPWpGaD
Cysteamine—Hypersensitivity—Methotrexate—breast cancer	9.55e-05	0.00025	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—RAF1—breast cancer	9.54e-05	0.000306	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—NRG1—breast cancer	9.49e-05	0.000304	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—H2AFX—breast cancer	9.42e-05	0.000302	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—IL2—breast cancer	9.42e-05	0.000302	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—SPP1—breast cancer	9.37e-05	0.000301	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—E2F1—breast cancer	9.35e-05	0.0003	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—CXCL8—breast cancer	9.33e-05	0.000299	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—PIK3CB—breast cancer	9.31e-05	0.000299	CbGpPWpGaD
Cysteamine—Asthenia—Methotrexate—breast cancer	9.3e-05	0.000243	CcSEcCtD
Cysteamine—SST—Signaling Pathways—ERBB3—breast cancer	9.27e-05	0.000297	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—FGFR2—breast cancer	9.26e-05	0.000297	CbGpPWpGaD
Cysteamine—Feeling abnormal—Doxorubicin—breast cancer	9.25e-05	0.000242	CcSEcCtD
Cysteamine—Gastrointestinal pain—Doxorubicin—breast cancer	9.18e-05	0.00024	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—SPP1—breast cancer	8.99e-05	0.000288	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—CXCL8—breast cancer	8.95e-05	0.000287	CbGpPWpGaD
Cysteamine—Hypersensitivity—Epirubicin—breast cancer	8.94e-05	0.000234	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—IL2—breast cancer	8.92e-05	0.000286	CbGpPWpGaD
Cysteamine—Urticaria—Doxorubicin—breast cancer	8.92e-05	0.000233	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—ERBB3—breast cancer	8.89e-05	0.000285	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—TERT—breast cancer	8.89e-05	0.000285	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—FGFR2—breast cancer	8.88e-05	0.000285	CbGpPWpGaD
Cysteamine—Body temperature increased—Doxorubicin—breast cancer	8.87e-05	0.000232	CcSEcCtD
Cysteamine—Abdominal pain—Doxorubicin—breast cancer	8.87e-05	0.000232	CcSEcCtD
Cysteamine—Diarrhoea—Methotrexate—breast cancer	8.87e-05	0.000232	CcSEcCtD
Cysteamine—Asthenia—Epirubicin—breast cancer	8.7e-05	0.000228	CcSEcCtD
Cysteamine—SST—Signaling Pathways—FGFR1—breast cancer	8.63e-05	0.000277	CbGpPWpGaD
Cysteamine—Dizziness—Methotrexate—breast cancer	8.57e-05	0.000224	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—IL2—breast cancer	8.55e-05	0.000274	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—TERT—breast cancer	8.52e-05	0.000273	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—HIF1A—breast cancer	8.5e-05	0.000272	CbGpPWpGaD
Cysteamine—Diarrhoea—Epirubicin—breast cancer	8.3e-05	0.000217	CcSEcCtD
Cysteamine—SST—Signaling Pathways—LEP—breast cancer	8.3e-05	0.000266	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—FGFR1—breast cancer	8.27e-05	0.000265	CbGpPWpGaD
Cysteamine—Hypersensitivity—Doxorubicin—breast cancer	8.27e-05	0.000216	CcSEcCtD
Cysteamine—Vomiting—Methotrexate—breast cancer	8.24e-05	0.000215	CcSEcCtD
Cysteamine—SST—Signaling Pathways—CAV1—breast cancer	8.22e-05	0.000264	CbGpPWpGaD
Cysteamine—Rash—Methotrexate—breast cancer	8.17e-05	0.000214	CcSEcCtD
Cysteamine—Dermatitis—Methotrexate—breast cancer	8.16e-05	0.000213	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—HIF1A—breast cancer	8.15e-05	0.000261	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—KDR—breast cancer	8.13e-05	0.000261	CbGpPWpGaD
Cysteamine—Headache—Methotrexate—breast cancer	8.12e-05	0.000212	CcSEcCtD
Cysteamine—Asthenia—Doxorubicin—breast cancer	8.05e-05	0.000211	CcSEcCtD
Cysteamine—Dizziness—Epirubicin—breast cancer	8.02e-05	0.00021	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—LEP—breast cancer	7.95e-05	0.000255	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—ESR1—breast cancer	7.92e-05	0.000254	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CAV1—breast cancer	7.88e-05	0.000253	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—FN1—breast cancer	7.82e-05	0.000251	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—KDR—breast cancer	7.79e-05	0.00025	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—NFKBIA—breast cancer	7.73e-05	0.000248	CbGpPWpGaD
Cysteamine—Vomiting—Epirubicin—breast cancer	7.71e-05	0.000202	CcSEcCtD
Cysteamine—Nausea—Methotrexate—breast cancer	7.7e-05	0.000201	CcSEcCtD
Cysteamine—Diarrhoea—Doxorubicin—breast cancer	7.68e-05	0.000201	CcSEcCtD
Cysteamine—SST—Signaling Pathways—NOTCH1—breast cancer	7.66e-05	0.000245	CbGpPWpGaD
Cysteamine—Rash—Epirubicin—breast cancer	7.65e-05	0.0002	CcSEcCtD
Cysteamine—Dermatitis—Epirubicin—breast cancer	7.64e-05	0.0002	CcSEcCtD
Cysteamine—Headache—Epirubicin—breast cancer	7.6e-05	0.000199	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—ESR1—breast cancer	7.59e-05	0.000243	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—FN1—breast cancer	7.5e-05	0.00024	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—KIT—breast cancer	7.49e-05	0.00024	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PIK3CG—breast cancer	7.49e-05	0.00024	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—APC—breast cancer	7.49e-05	0.00024	CbGpPWpGaD
Cysteamine—Dizziness—Doxorubicin—breast cancer	7.42e-05	0.000194	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—NFKBIA—breast cancer	7.41e-05	0.000238	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—EGF—breast cancer	7.4e-05	0.000237	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—NOTCH1—breast cancer	7.34e-05	0.000235	CbGpPWpGaD
Cysteamine—Nausea—Epirubicin—breast cancer	7.2e-05	0.000188	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—APC—breast cancer	7.18e-05	0.00023	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PIK3CG—breast cancer	7.18e-05	0.00023	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—KIT—breast cancer	7.18e-05	0.00023	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—MAPK3—breast cancer	7.17e-05	0.00023	CbGpPWpGaD
Cysteamine—Vomiting—Doxorubicin—breast cancer	7.14e-05	0.000187	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—EGF—breast cancer	7.1e-05	0.000227	CbGpPWpGaD
Cysteamine—Rash—Doxorubicin—breast cancer	7.08e-05	0.000185	CcSEcCtD
Cysteamine—Dermatitis—Doxorubicin—breast cancer	7.07e-05	0.000185	CcSEcCtD
Cysteamine—SST—Signaling Pathways—BRAF—breast cancer	7.04e-05	0.000226	CbGpPWpGaD
Cysteamine—Headache—Doxorubicin—breast cancer	7.03e-05	0.000184	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—MAPK3—breast cancer	6.87e-05	0.00022	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—IGF1—breast cancer	6.86e-05	0.00022	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—AKT2—breast cancer	6.85e-05	0.00022	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—EGFR—breast cancer	6.82e-05	0.000219	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—BRAF—breast cancer	6.75e-05	0.000216	CbGpPWpGaD
Cysteamine—Nausea—Doxorubicin—breast cancer	6.67e-05	0.000174	CcSEcCtD
Cysteamine—SST—Signaling Pathways—PIK3CD—breast cancer	6.58e-05	0.000211	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—IGF1—breast cancer	6.57e-05	0.000211	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—AKT2—breast cancer	6.57e-05	0.000211	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—EGFR—breast cancer	6.54e-05	0.00021	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—PIK3CA—breast cancer	6.52e-05	0.000209	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—SERPINE1—breast cancer	6.51e-05	0.000209	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—KRAS—breast cancer	6.44e-05	0.000207	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PIK3CD—breast cancer	6.31e-05	0.000202	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—PIK3CA—breast cancer	6.25e-05	0.0002	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—SERPINE1—breast cancer	6.24e-05	0.0002	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—NOS3—breast cancer	6.22e-05	0.000199	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—KRAS—breast cancer	6.18e-05	0.000198	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—NOS3—breast cancer	5.96e-05	0.000191	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—PIK3CA—breast cancer	5.92e-05	0.00019	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—MDM2—breast cancer	5.9e-05	0.000189	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—RAF1—breast cancer	5.88e-05	0.000188	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—RELA—breast cancer	5.85e-05	0.000188	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—ERBB2—breast cancer	5.81e-05	0.000186	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—MTOR—breast cancer	5.74e-05	0.000184	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PIK3CB—breast cancer	5.74e-05	0.000184	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—PIK3CA—breast cancer	5.68e-05	0.000182	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—MDM2—breast cancer	5.65e-05	0.000181	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—RAF1—breast cancer	5.63e-05	0.000181	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—RELA—breast cancer	5.61e-05	0.00018	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—ERBB2—breast cancer	5.57e-05	0.000179	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CXCL8—breast cancer	5.51e-05	0.000177	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PIK3CB—breast cancer	5.5e-05	0.000176	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—MTOR—breast cancer	5.5e-05	0.000176	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—HRAS—breast cancer	5.48e-05	0.000176	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CDKN1B—breast cancer	5.38e-05	0.000173	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—AKT1—breast cancer	5.33e-05	0.000171	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CXCL8—breast cancer	5.29e-05	0.000169	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CASP3—breast cancer	5.28e-05	0.000169	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—IL2—breast cancer	5.27e-05	0.000169	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—HRAS—breast cancer	5.25e-05	0.000168	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—IL6—breast cancer	5.24e-05	0.000168	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CDKN1B—breast cancer	5.16e-05	0.000165	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CCND1—breast cancer	5.14e-05	0.000165	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—JUN—breast cancer	5.13e-05	0.000164	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—AKT1—breast cancer	5.11e-05	0.000164	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CTNNB1—breast cancer	5.09e-05	0.000163	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CASP3—breast cancer	5.06e-05	0.000162	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—IL2—breast cancer	5.05e-05	0.000162	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—IL6—breast cancer	5.03e-05	0.000161	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—MMP9—breast cancer	4.99e-05	0.00016	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CDKN1A—breast cancer	4.97e-05	0.000159	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PTEN—breast cancer	4.96e-05	0.000159	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CCND1—breast cancer	4.92e-05	0.000158	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—JUN—breast cancer	4.91e-05	0.000158	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CTNNB1—breast cancer	4.88e-05	0.000156	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—MAPK8—breast cancer	4.85e-05	0.000155	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—AKT1—breast cancer	4.84e-05	0.000155	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—MMP9—breast cancer	4.78e-05	0.000153	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CDKN1A—breast cancer	4.76e-05	0.000153	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PTEN—breast cancer	4.75e-05	0.000152	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—MAPK8—breast cancer	4.65e-05	0.000149	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—AKT1—breast cancer	4.64e-05	0.000149	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—SRC—breast cancer	4.6e-05	0.000147	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—VEGFA—breast cancer	4.48e-05	0.000144	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—STAT3—breast cancer	4.43e-05	0.000142	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—SRC—breast cancer	4.41e-05	0.000141	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—VEGFA—breast cancer	4.29e-05	0.000138	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—STAT3—breast cancer	4.25e-05	0.000136	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—MAPK3—breast cancer	4.24e-05	0.000136	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—MYC—breast cancer	4.12e-05	0.000132	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—TGFB1—breast cancer	4.11e-05	0.000132	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—MAPK3—breast cancer	4.06e-05	0.00013	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—EGFR—breast cancer	4.03e-05	0.000129	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—MYC—breast cancer	3.95e-05	0.000127	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—TGFB1—breast cancer	3.94e-05	0.000126	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—EGFR—breast cancer	3.86e-05	0.000124	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—KRAS—breast cancer	3.81e-05	0.000122	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—KRAS—breast cancer	3.65e-05	0.000117	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PIK3CA—breast cancer	3.5e-05	0.000112	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—TP53—breast cancer	3.38e-05	0.000108	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PIK3CA—breast cancer	3.35e-05	0.000108	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—TP53—breast cancer	3.24e-05	0.000104	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—HRAS—breast cancer	3.24e-05	0.000104	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—HRAS—breast cancer	3.1e-05	9.95e-05	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—IL6—breast cancer	3.1e-05	9.93e-05	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—IL6—breast cancer	2.97e-05	9.52e-05	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—AKT1—breast cancer	2.86e-05	9.16e-05	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—AKT1—breast cancer	2.74e-05	8.78e-05	CbGpPWpGaD
